156 related articles for article (PubMed ID: 35594765)
1. Ultrasound assisted one-pot synthesis of rosuvastatin based novel azaindole derivatives via coupling-cyclization strategy under Pd/Cu-catalysis: Their evaluation as potential cytotoxic agents.
Kumar JS; Reddy GS; Medishetti R; Amirul Hossain K; Thirupataiah B; Edelli J; Dilip Bele S; Kristina Edwin R; Joseph A; Shenoy GG; Mallikarjuna Rao C; Pal M
Bioorg Chem; 2022 Jul; 124():105857. PubMed ID: 35594765
[TBL] [Abstract][Full Text] [Related]
2. Rosuvastatin based novel 3-substituted isocoumarins / 3-alkylidenephthalides: Ultrasound assisted synthesis and identification of new anticancer agents.
Kumar JS; Thirupataiah B; Medishetti R; Ray A; Bele SD; Hossain KA; Reddy GS; Edwin RK; Joseph A; Kumar N; Shenoy GG; Rao CM; Pal M
Eur J Med Chem; 2020 Sep; 201():112335. PubMed ID: 32599323
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 2-substituted Furo[3,2-b]pyridines Under Pd/C-Cu Catalysis Assisted by Ultrasound: Their Evaluation as Potential Cytotoxic Agents.
Laxmi DS; Vardhini SV; Guttikonda VR; Rao MVB; Pal M
Anticancer Agents Med Chem; 2020; 20(8):932-940. PubMed ID: 32160853
[TBL] [Abstract][Full Text] [Related]
4. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
Maher M; Kassab AE; Zaher AF; Mahmoud Z
Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
6. 6-Bromoquinazoline Derivatives as Potent Anticancer Agents: Synthesis, Cytotoxic Evaluation, and Computational Studies.
Zare S; Emami L; Behrouz M; Khankahdani RA; Nickpour S; Emami M; Faghih Z; Khabnadideh S
Chem Biodivers; 2023 Jul; 20(7):e202201245. PubMed ID: 37191970
[TBL] [Abstract][Full Text] [Related]
7. Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors.
Saleh NM; El-Gaby MSA; El-Adl K; Abd El-Sattar NEA
Bioorg Chem; 2020 Nov; 104():104350. PubMed ID: 33142416
[TBL] [Abstract][Full Text] [Related]
8. CuCl
Thirupataiah B; Mounika G; Sujeevan Reddy G; Sandeep Kumar J; Kapavarapu R; Medishetti R; Mudgal J; Mathew JE; Shenoy GG; Mallikarjuna Rao C; Chatti K; V L Parsa K; Pal M
Bioorg Chem; 2021 Oct; 115():105265. PubMed ID: 34426160
[TBL] [Abstract][Full Text] [Related]
9. Discovery of new anticancer thiourea-azetidine hybrids: design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies.
Parmar DR; Soni JY; Guduru R; Rayani RH; Kusurkar RV; Vala AG; Talukdar SN; Eissa IH; Metwaly AM; Khalil A; Zunjar V; Battula S
Bioorg Chem; 2021 Oct; 115():105206. PubMed ID: 34339975
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.
Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M
Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and SAR of novel 7-azaindole derivatives as potential Erk5 kinase inhibitor with anticancer activity.
Zhang Q; Gao X; Duan X; Liang H; Gao M; Dong D; Guo C; Huang L
Bioorg Med Chem; 2023 Nov; 95():117503. PubMed ID: 37862935
[TBL] [Abstract][Full Text] [Related]
12. Novel Gomisin B analogues as potential cytotoxic agents: Design, synthesis, biological evaluation and docking studies.
Poornima B; Siva B; Venkanna A; Shankaraiah G; Jain N; Yadav DK; Misra S; Babu KS
Eur J Med Chem; 2017 Oct; 139():441-453. PubMed ID: 28818768
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of novel carbohydrate-based sulfonamide derivatives as antitumor agents.
Hao S; Cheng X; Wang X; An R; Xu H; Guo M; Li C; Wang Y; Hou Z; Guo C
Bioorg Chem; 2020 Nov; 104():104237. PubMed ID: 32911194
[TBL] [Abstract][Full Text] [Related]
15. Targeting the interplay between MMP-2, CA II and VEGFR-2 via new sulfonamide-tethered isomeric triazole hybrids; Microwave-assisted synthesis, computational studies and evaluation.
Reda Aouad M; Almehmadi MA; Faleh Albelwi F; Teleb M; Tageldin GN; Abu-Serie MM; Hagar M; Rezki N
Bioorg Chem; 2022 Jul; 124():105816. PubMed ID: 35489270
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound Assisted Synthesis of 3,4-Diyne Substituted Isocoumarin Derivatives: Identification of Potential Cytotoxic Agents.
Suman K; Rao KP; Anuradha V; Rao MVB; Pal M
Mini Rev Med Chem; 2018; 18(12):1064-1070. PubMed ID: 29468966
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis and Biological Evaluation of Novel N-hydroxyheptanamides Incorporating 6-hydroxy-2-methylquinazolin-4(3H)-ones as Histone Deacetylase Inhibitors and Cytotoxic Agents.
Minh NV; Thanh NT; Lien HT; Anh DTP; Cuong HD; Nam NH; Hai PT; Minh-Ngoc L; Le-Thi-Thu H; Chinh LV; Vu TK
Anticancer Agents Med Chem; 2019; 19(12):1543-1557. PubMed ID: 31267876
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, anticancer evaluation and molecular docking studies of new heterocycles linked to sulfonamide moiety as novel human topoisomerase types I and II poisons.
Halawa AH; Elgammal WE; Hassan SM; Hassan AH; Nassar HS; Ebrahim HY; Mehany ABM; El-Agrody AM
Bioorg Chem; 2020 May; 98():103725. PubMed ID: 32199303
[TBL] [Abstract][Full Text] [Related]
19. Novel p-Functionalized Chromen-4-on-3-yl Chalcones Bearing Astonishing Boronic Acid Moiety as MDM2 Inhibitor: Synthesis, Cytotoxic Evaluation and Simulation Studies.
Bhatia RK; Singh L; Garg R; Kaur M; Yadav M; Madan J; Kancherla S; Pissurlenkar RRS; Coutinho EC
Med Chem; 2020; 16(2):212-228. PubMed ID: 31146672
[TBL] [Abstract][Full Text] [Related]
20. Development of novel cyanopyridines as PIM-1 kinase inhibitors with potent anti-prostate cancer activity: Synthesis, biological evaluation, nanoparticles formulation and molecular dynamics simulation.
Ibrahim MH; Harras MF; Mostafa SK; Mohyeldin SM; Al Kamaly O; Altwaijry N; Sabour R
Bioorg Chem; 2022 Dec; 129():106122. PubMed ID: 36084418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
